Abstract: The exemplary embodiments of the present invention provide a quantum random number generation apparatus according to an exemplary embodiment of the present invention including: a space-division semiconductor detector including a plurality of cells, each individually absorbing a plurality of emission particles emitted from a radioactive isotope; and a signal processor that generates a random number based on an absorption event at which the plurality of emission particles are absorbed into the plurality of cells, and thus new type of random number conversion method that combines a spatial randomness and existing temporal randomness of the emission particle can be provided, there is no restriction generated due to the dead time, the random number generation rate can be remarkably increased, and it is possible to generate of a pure random number at high speed, which is required by a computer, a network processor, or an IoT device.

Abstract: An anti-STAT3 specific antibody and a pharmaceutical composition comprising the same is provided. The anti-STAT3 specific antibody includes a site that specifically binds to STAT3, and further includes a STAT3 site plus a DNA binding site that confer cell penetration ability, and the pharmaceutical composition includes the anti-STAT3 specific antibody as an active ingredient. The STAT3 specific antibody, and particularly the STAT3/DNA dual specific antibody having a dual specific characteristic, contains a DNA binding site that can penetrate cells and specifically bind to DNA in the nucleus, and thus can overcome the limitations of conventional antibody therapeutics that can target only extracellular proteins. The antibody can inhibit transcription factor activity of STAT3 by specifically binding to phosphorylated activated form of STAT3. Thus, the antibody could be used for the development of a therapeutic agent without side effects for various diseases caused by activation of STAT3.

Abstract: An anti-STAT3 specific antibody and a pharmaceutical composition comprising the same is provided. The anti-STAT3 specific antibody includes a site that specifically binds to STAT3, and further includes a STAT3 site plus a DNA binding site that confer cell penetration ability, and the pharmaceutical composition includes the anti-STAT3 specific antibody as an active ingredient. The STAT3 specific antibody, and particularly the STAT3/DNA dual specific antibody having a dual specific characteristic, contains a DNA binding site that can penetrate cells and specifically bind to DNA in the nucleus, and thus can overcome the limitations of conventional antibody therapeutics that can target only extracellular proteins. The antibody can inhibit transcription factor activity of STAT3 by specifically binding to phosphorylated activated form of STAT3. Thus, the antibody could be used for the development of a therapeutic agent without side effects for various diseases caused by activation of STAT3.

Abstract: An anti-STAT3 specific antibody and a pharmaceutical composition comprising the same is provided. The anti-STAT3 specific antibody includes a site that specifically binds to STAT3, and further includes a STAT3 site plus a DNA binding site that confer cell penetration ability, and the pharmaceutical composition includes the anti-STAT3 specific antibody as an active ingredient. The STAT3 specific antibody, and particularly the STAT3/DNA dual specific antibody having a dual specific characteristic, contains a DNA binding site that can penetrate cells and specifically bind to DNA in the nucleus, and thus can overcome the limitations of conventional antibody therapeutics that can target only extracellular proteins. The antibody can inhibit transcription factor activity of STAT3 by specifically binding to phosphorylated activated form of STAT3. Thus, the antibody could be used for the development of a therapeutic agent without side effects for various diseases caused by activation of STAT3.

Abstract: The exemplary embodiments of the present invention provide a quantum random number generation apparatus according to an exemplary embodiment of the present invention including: a space-division semiconductor detector including a plurality of cells, each individually absorbing a plurality of emission particles emitted from a radioactive isotope; and a signal processor that generates a random number based on an absorption event at which the plurality of emission particles are absorbed into the plurality of cells, and thus new type of random number conversion method that combines a spatial randomness and existing temporal randomness of the emission particle can be provided, there is no restriction generated due to the dead time, the random number generation rate can be remarkably increased, and it is possible to generate of a pure random number at high speed, which is required by a computer, a network processor, or an IoT device.

Abstract: A core pack manufacturing apparatus for preventing or substantially preventing an iron from contacting a cell or a protective circuit part in a process of soldering a connection tab of the cell to a connection terminal of the protective circuit part. A core pack manufacturing apparatus for soldering a connection tab connected to a cell to a connection terminal of a protective circuit part includes a cap including a first cover configured to cover the cell, and a second cover extending from a side of the first cover and configured to cover the protective circuit part, the second cover having an opening part configured to expose the connection tab and the connection terminal through the second cover for soldering.

Abstract: A battery pack and a method for fabricating the same are provided. The battery pack includes a plurality of battery cells connected in series or in parallel to each other, a protective circuit module (PCM) controlling charging and discharging of the plurality of battery cells, and a coverlay electrically connecting the plurality of battery cells to the PCM, wherein the coverlay includes a plurality of wires, each of the plurality of wires includes battery connecting pads provided at its one end, the battery connecting pads connected to the battery cells, and module connecting pads provided at it's the other end, the module connecting pads connected to the PCM, and a solder layer is formed on the battery connecting pads.

Abstract: A battery pack and a method for fabricating the same are provided. The battery pack includes a plurality of battery cells connected in series or in parallel to each other, a protective circuit module (PCM) controlling charging and discharging of the plurality of battery cells, and a coverlay electrically connecting the plurality of battery cells to the PCM, wherein the coverlay includes a plurality of wires, each of the plurality of wires includes battery connecting pads provided at its one end, the battery connecting pads connected to the battery cells, and module connecting pads provided at it's the other end, the module connecting pads connected to the PCM, and a solder layer is formed on the battery connecting pads.

Abstract: The present invention relates to a secondary battery, and in particular relating to a secondary battery in which connection between the bare cell and the protection circuit can be established by a mechanical connection system without using molding method. A secondary battery of the present invention includes a bare cell in which charging and discharging can be performed, a protection circuit substrate electrically connected to the bare cell, a substrate molding body integrally formed with the protection circuit substrate, a support member having a connection unit coupled to the substrate molding body for connecting the substrate molding body to the support member, and a connection member for connecting the substrate molding body to the connection unit.

Abstract: A battery pack and a method for fabricating the same are provided. The battery pack includes a plurality of battery cells connected in series or in parallel to each other, a protective circuit module (PCM) controlling charging and discharging of the plurality of battery cells, and a coverlay electrically connecting the plurality of battery cells to the PCM, wherein the coverlay includes a plurality of wires, each of the plurality of wires includes battery connecting pads provided at its one end, the battery connecting pads connected to the battery cells, and module connecting pads provided at it's the other end, the module connecting pads connected to the PCM, and a solder layer is formed on the battery connecting pads.

Abstract: A core pack manufacturing apparatus for preventing or substantially preventing an iron from contacting a cell or a protective circuit part in a process of soldering a connection tab of the cell to a connection terminal of the protective circuit part. A core pack manufacturing apparatus for soldering a connection tab connected to a cell to a connection terminal of a protective circuit part includes a cap including a first cover configured to cover the cell, and a second cover extending from a side of the first cover and configured to cover the protective circuit part, the second cover having an opening part configured to expose the connection tab and the connection terminal through the second cover for soldering.

Abstract: A battery pack and a method for fabricating the same are provided. The battery pack includes a plurality of battery cells connected in series or in parallel to each other, a protective circuit module (PCM) controlling charging and discharging of the plurality of battery cells, and a coverlay electrically connecting the plurality of battery cells to the PCM, wherein the coverlay includes a plurality of wires, each of the plurality of wires includes battery connecting pads provided at its one end, the battery connecting pads connected to the battery cells, and module connecting pads provided at it's the other end, the module connecting pads connected to the PCM, and a solder layer is formed on the battery connecting pads.

Abstract: A battery pack that includes a plurality of bare cells including a first bare cell and a second bare cell, and a lead plate electrically connecting the first bare cell and the second bare cell. A bent area of the lead plate may be provided with a hole or a groove.

Abstract: The present invention relates to a hybridoma cell line producing a PPAR gamma-specific monoclonal antibody, and a method for detecting a PPAR gamma ligand related to the progression of difficult diseases, such as cancer, inflammation and metabolic diseases obesity and diabetes), using the PPAR gamma-specific monoclonal antibody. This PPAR gamma-specific monoclonal antibody and the method for screening a PPAR gamma ligand using the monoclonal antibody will be commercially used for screening a PPAR gamma regulator related to diseases such as inflammatory, cancer and metabolic diseases, and also will serve as an useful tool for analyzing the function of such a ligand.

Abstract: The present invention relates to a secondary battery, and in particular relating to a secondary battery in which connection between the bare cell and the protection circuit can be established by a mechanical connection system without using molding method. A secondary battery of the present invention includes a bare cell in which charging and discharging can be performed, a protection circuit substrate electrically connected to the bare cell, a substrate molding body integrally formed with the protection circuit substrate, a support member having a connection unit coupled to the substrate molding body for connecting the substrate molding body to the support member, and a connection member for connecting the substrate molding body to the connection unit.

Abstract: The present invention relates to a hybridoma cell line producing a PPAR gamma-specific monoclonal antibody, and a method for detecting a PPAR gamma ligand related to the progression of difficult diseases, such as cancer, inflammation and metabolic diseases obesity and diabetes), using the PPAR gamma-specific monoclonal antibody. This PPAR gamma-specific monoclonal antibody and the method for screening a PPAR gamma ligand using the monoclonal antibody will be commercially used for screening a PPAR gamma regulator related to diseases such as inflammatory, cancer and metabolic diseases, and also will serve as an useful tool for analyzing the function of such a ligand.